With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Office-based endometrial ablation for menorrhagia is equally effective with thermal balloon ablation or bipolar radiofrequency, U.K. researchers say. Six months after randomization and…
NEW YORK (Reuters Health) – Menses and ovulation are more likely to resume spontaneously after chemotherapy if women also receive a gonadotropin-releasing hormone (GnRH) analog – but pregnancy…
NEW YORK (Reuters Health) – Noninvasive uterine electromyography (EMG) identifies true preterm labor more accurately than clinical methods now in use, new research shows. “It can therefore identify…
NEW YORK (Reuters Health) – While elevated levels of anticardiolipin antibodies are associated with preeclampsia, measuring levels of anticardiolipin antibodies cannot be used to predict risk of preeclampsia…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…
NEW YORK (Reuters Health) – Routine screening for coagulation abnormalities before oocyte retrieval for in vitro fertilization (IVF) is costly and not clinically effective, researchers from Israel found…
NEW YORK (Reuters Health) – Magnetic resonance imaging of ovarian tumors is useful in predicting whether the lesion is malignant or benign, thereby helping to guide the therapeutic…
NEW YORK (Reuters Health) – The likelihood that a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive breast cancer on final…
NEW YORK (Reuters Health) – A selective with antiprogestin effects, CDB-2914, reduces uterine fibroid size and bleeding, and improves quality of life in affected women, according to a…
